Počet záznamov: 1
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
- Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE / P. Schöffski, Kubickova M. ... [et al.]. Onkológia Roč. 17, č. 1 (2022), s. 68
článok
Počet záznamov: 1